GSK
Income statement / Annual
Last year (2024), GSK plc's total revenue was $31.38 B,
an increase of 3.46% from the previous year.
In 2024, GSK plc's net income was $2.58 B.
See GSK plc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$31.38 B |
$30.33 B |
$29.32 B |
$24.70 B |
$24.35 B |
$33.75 B |
$30.82 B |
$30.19 B |
$27.89 B |
$23.92 B |
| Cost of Revenue |
$9.05 B
|
$8.57 B
|
$9.55 B
|
$8.16 B
|
$7.93 B
|
$11.86 B
|
$10.24 B
|
$10.34 B
|
$9.29 B
|
$8.85 B
|
| Gross Profit |
$22.33 B
|
$21.76 B
|
$19.77 B
|
$16.53 B
|
$16.43 B
|
$21.89 B
|
$20.58 B
|
$19.84 B
|
$18.60 B
|
$15.07 B
|
| Gross Profit Ratio |
0.71
|
0.72
|
0.67
|
0.67
|
0.67
|
0.65
|
0.67
|
0.66
|
0.67
|
0.63
|
| Research and Development Expenses |
$6.40 B
|
$6.22 B
|
$5.49 B
|
$5.02 B
|
$4.79 B
|
$4.57 B
|
$3.89 B
|
$4.48 B
|
$3.63 B
|
$3.56 B
|
| General & Administrative Expenses |
$11.02 B
|
$9.39 B
|
$8.37 B
|
$7.07 B
|
$7.44 B
|
$11.40 B
|
$9.92 B
|
$9.67 B
|
$9.37 B
|
$9.23 B
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$11.02 B
|
$9.39 B
|
$8.37 B
|
$7.07 B
|
$7.44 B
|
$11.40 B
|
$9.92 B
|
$9.67 B
|
$9.37 B
|
$9.23 B
|
| Other Expenses |
$891.00 M
|
-$590.00 M
|
-$523.00 M
|
$87.00 M
|
-$1.78 B
|
-$1.04 B
|
$1.29 B
|
$1.61 B
|
$3.01 B
|
-$8.04 B
|
| Operating Expenses |
$18.31 B
|
$15.02 B
|
$13.34 B
|
$12.18 B
|
$10.45 B
|
$14.93 B
|
$15.10 B
|
$15.76 B
|
$16.00 B
|
$4.75 B
|
| Cost And Expenses |
$27.36 B
|
$23.58 B
|
$22.89 B
|
$20.34 B
|
$18.38 B
|
$26.79 B
|
$25.34 B
|
$26.10 B
|
$25.29 B
|
$13.60 B
|
| Interest Income |
$67.39 M
|
$40.00 M
|
$64.27 M
|
$28.00 M
|
$44.00 M
|
$98.00 M
|
$77.84 M
|
$65.00 M
|
$72.00 M
|
$104.00 M
|
| Interest Expense |
$657.58 M
|
$775.00 M
|
$855.53 M
|
$784.00 M
|
$892.00 M
|
$912.00 M
|
$743.64 M
|
$734.00 M
|
$736.00 M
|
$757.00 M
|
| Depreciation & Amortization |
$2.55 B
|
$2.29 B
|
$2.15 B
|
$2.12 B
|
$2.05 B
|
$2.12 B
|
$1.86 B
|
$1.92 B
|
$1.77 B
|
$1.63 B
|
| EBITDA |
$6.67 B |
$9.08 B |
$8.60 B |
$6.49 B |
$8.07 B |
$9.22 B |
$7.35 B |
$6.18 B |
$4.43 B |
$12.89 B |
| EBITDA Ratio |
0.21
|
0.3
|
0.29
|
0.26
|
0.33
|
0.27
|
0.24
|
0.2
|
0.16
|
0.54
|
| Operating Income Ratio |
0.13
|
0.22
|
0.22
|
0.18
|
0.25
|
0.21
|
0.18
|
0.14
|
0.09
|
0.43
|
| Total Other Income/Expenses Net |
-$544.00 M
|
-$681.00 M
|
-$805.00 M
|
-$758.00 M
|
-$809.00 M
|
-$740.00 M
|
-$683.00 M
|
-$562.00 M
|
-$659.00 M
|
$204.00 M
|
| Income Before Tax |
$3.48 B
|
$6.06 B
|
$5.63 B
|
$3.60 B
|
$5.17 B
|
$6.22 B
|
$4.80 B
|
$3.53 B
|
$1.94 B
|
$10.53 B
|
| Income Before Tax Ratio |
0.11
|
0.2
|
0.19
|
0.15
|
0.21
|
0.18
|
0.16
|
0.12
|
0.07
|
0.44
|
| Income Tax Expense |
$526.00 M
|
$756.00 M
|
$707.00 M
|
$83.00 M
|
$67.00 M
|
$953.00 M
|
$754.00 M
|
$1.36 B
|
$877.00 M
|
$2.15 B
|
| Net Income |
$2.58 B
|
$4.93 B
|
$14.96 B
|
$4.39 B
|
$5.75 B
|
$4.65 B
|
$3.62 B
|
$1.53 B
|
$912.00 M
|
$8.42 B
|
| Net Income Ratio |
0.08
|
0.16
|
0.51
|
0.18
|
0.24
|
0.14
|
0.12
|
0.05
|
0.03
|
0.35
|
| EPS |
1.26 |
2.44 |
2.44 |
2.74 |
2.88 |
2.34 |
1.84 |
0.78 |
0.48 |
4.36 |
| EPS Diluted |
1.24 |
2.4 |
2.4 |
2.7 |
2.86 |
2.32 |
1.82 |
0.78 |
0.46 |
4.3 |
| Weighted Average Shares Out |
$2.04 B
|
$2.03 B
|
$2.01 B
|
$1.60 B
|
$1.99 B
|
$1.98 B
|
$1.97 B
|
$1.95 B
|
$1.94 B
|
$1.93 B
|
| Weighted Average Shares Out Diluted |
$2.07 B
|
$2.06 B
|
$2.04 B
|
$1.62 B
|
$2.02 B
|
$2.01 B
|
$1.99 B
|
$1.98 B
|
$1.96 B
|
$1.96 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
